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Abstract.  We have developed an analytical, ligand-specific and scalable algorithm that detects a ‘signature’ of the 3D 
binding site of a given ligand in a protein 3D structure.   The said signature is a 3D motif in the form of an irregular 
tetrahedron whose vertices represent the backbone or side-chain centroids of the amino acid residues at the binding 
site that physically interact with the bound ligand atoms.  The motif is determined from a set of solved training 
structures, all of which bind the ligand.  Just as alignment of linear amino acid sequences enables one to determine 
consensus sequences in proteins, the present method allows the determination of three-dimensional consensus 
structures or ‘motifs’ in folded proteins. Although such is accomplished by the present method not by alignment of 3D 
protein structures or parts thereof (e.g., alignment of ligand atoms from different structures) but by nearest-neighbor 
analysis of ligand atoms in protein-bound forms, the same effect, and thus the same goal, is achieved.  We have 
applied our method to the prediction of GTP- and ATP-binding protein families, namely, the small Ras-type G-protein 
and ser/thr protein kinase families. Validation tests reveal that the specificity of our method is nearly 100% for both 
protein families, and a sensitivity of ≥ 60% for the ser/thr protein kinase family and approx. 93% for the small, Ras-
type G-protein family. Further tests reveal that our algorithm can distinguish effectively between GTP and GTP-like 
ligands, and between ATP- and ATP-like ligands.  The method was applied to a set of predicted (by 123D threading) 
protein structures from the slime mold (D. dictyostelium) proteome, with promising results.    
 
Keywords:  specific ligand binding site prediction, protein-ligand interactions, exact (analytical) algorithm, 3D 
consensus motif, ATP-binding proteins, GTP-binding proteins, ser/thr protein kinases, small Ras-type G-
proteins, 3D ligand binding site motif, reduced protein representation, proteome functional annotation, protein 
function prediction 
 
1  Introduction 
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Motivation and Background.  The last 10-15 years saw genome sequencing efforts around the world give rise to a 
deluge of genetic sequence information, a significant percentage of which code for novel proteins of unknown 
function (Bentley & Parkhill, 2004; Murphy et al., 2004; Holm & Sander, 1996; Baxevanis, 2003; Miller et al., 2004).  
Currently there are approximately 1,500 gene sequences deposited in GenBank per protein structure deposited in the 
PDB; by mid-2010, this imbalance is projected to reach a rate of over 5,000 gene sequences in GenBank per structure 
in the PDB, even though structural genomics projects have been steadily producing experimental structures of proteins 
with novel folds and unknown functions (Berman & Westbrook, 2004; Yakunin et al., 2004; Jung & Lee, 2004; 
Norvell & Machalek, 2000; Burley, 2000; Terwilliger, 2000; Heinemann, 2000; Yokoyama et al., 2000).  This work 
addresses the need for structure-based approaches to protein function prediction by (a.) the assignment of putative 
functions for these proteins based on their solved structures, and (b.) the prediction of function of proteins which are 
unsolved but which have acceptably accurate 3D structure models predicted from their sequences; in this case, the 
function is predicted from the 3D models. Our approach to this problem is to devise an analytical and automatable 
(hence amenable to high-throughput implementation) procedure that can predict which ligand binding site a given 
protein harbors, given its 3D structure. We apply the method to the prediction of ATP- and GTP-binding proteins. 
 
Overview of the Methodology.   The basic underlying idea behind our method is shown in Figure 1.  The amino acid 
residues (R1, R2, R3 and R4) contacting the ligand at its binding site are generally far apart in primary sequence and 
occur in no particular order.  They interact with specific ligand atoms either via hydrogen bonding or van der Waals 
interactions, and either via side-chain or backbone.  The identities of the amino acids are conserved to varying 
degrees, but in general they are more conserved if the interaction with ligand is via side-chain than if via backbone.  
Their relative distances are also generally conserved, as these are dictated by the ligand’s molecular dimensions 
(which are constant), and bound conformation (often, but not always, conserved).   
                             
Our overall methodology may be deemed as a three-stage procedure (see Figure 2), namely, determination of the 
tertrahedral  ‘three-dimensional search motif’ (3D SM) from the training set (part I), validation of the 3D SM using the 
positive and negative control structures (part II), and the application of the 3D SM search algorithm to proteins of 
unknown function , i.e., with unknown ligand binding sites (part III) .  
 
In part I, the ‘binding site consensus motif’ - the collection of physical interactions, namely, H-bonds and VDW 
interactions, between the ligand and its binding site in the receptor protein  - of the ligand of interest is first determined 
from a set of training structures.  The training protein structures are first transformed into the ‘double-centroid reduced 
representation’ (DCRR).  The 3D SM is then derived from the consensus motif.  The relation between the usual all-
atom representation of a protein (as in the PDB) and its corresponding DCRR is shown in Figure 3.  In DCRR, each 
amino acid residue of the protein is represented by two points: the centroid of its backbone atoms (N, CA, C’, O), and 
the centroid of its side-chain atoms (CB, CG, etc.), reducing the atomicity of the protein by >76%.    
 
The resulting 3D SM is shown in Figure 4.  The 3D SM is an irregular tetrahedron whose four vertices are the 
centroids of the backbone and/or side-chain atoms of the residues making the major interactions with the ligand in its 
binding site (ligand binding site, LBS).   
 
The 3D SM is next validated in par t II using positive and negative control structures. These are, respectively, 
experimentally solved protein structures which are known to be able to bind, and be unable to bind, the ligand of 
interest.  ROC curves and then plotted to assess the sensitivity and specificity of the procedure using the 3D SM. 
                  
Part III is simply the actual application of the method to proteins of unknown function. This involves the screening for 
the presence of the 3D SM in the test set: the set of experimental or predicted structures of proteins whose functions 
are being sought, the functional assignment being inferred from the presence or absence of the 3D SM.  To implement 
the algorithm, the four vertices of the tetrahedral 3D SM must be in ‘tree’ data structure, i.e., exactly one (arbitrarily 
selected) must be designated as the ‘root’, and the other three, ‘node1’, ‘node2’ and ‘node3’, designated as ‘n1’, ‘n2’ 
and ‘n3’, respectively (sometimes designated as ‘e1’, ‘e2’ and ‘e3’, respectively, as well).   Our screening algorithm is 
written in Fortran77 and 90, and requires the parameters of the 3D SM, as input (i.e., the identities of the amino acid 
residues making up the 3D SM, the lengths of its 6 sides, and the nature of their interaction with the ligand, i.e., via 
backbone or via side chain, a total of at least 14 parameters).  Candidate 3D SM ‘sides’ are sequestered by the 
algorithm from the test protein structure 3D structure based on the input parameters as well as the ‘connectivity’ (i.e., 
whether each node is connected to the same root, as well as to each other).  In ascertaining connectivity, groups of 
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centroids called’ clusters’ are first selected, from which groups called ‘trees’ are further selected. An ‘error margin’, ε, 
typically ±1.4 Å, is added to the lengths of the sides of the 3D SM to incorporate a fuzzy element into the screening 
process.   
 
   
 
2  Methods,  Procedures  and  Datasets 
 
 Selection of Training Sets.   As both GTP- and ATP-binding proteins are both very heterogeneous, we decided to 
focus on the small, Ras-tywe G-protein and the ser/thr protein kinase families.   The training structures for the GTP-
binding small, Ras-type G-protein family are shown and described in Table 1, Panel A. All are small Ras-type G-
proteins except 1LOO, which, interestingly, is mouse muscle adenylosuccinate synthetase.  The training structures for 
ATP-binding ser/thr protein kinase family are shown and described in Table 1, Panel B.  All are CDK2, except for 
1GOl, which is a MAPK, and 1PHK, 2PHK and 1QL6, which are phosphorylase kinases.  All training structures have 
bound GTP or ATP, and not analogs, since analogs are known sometimes to bind in a novel fashion with the receptor 
protein (as exemplified by dihydrofolate reductase with bound folate versus methotrexate, see Matthews et al., 1977; 
Bystroff et al., 1990). 
 
Determining the 3D Ligand Binding Site Consensus Motif.   All calculations and operations were done using Fortran 
77 or 90 programs and UNIX scripts.   Nearest neighbors of each ligand atom in thet raining proteins in all-atom 
representation (AAR) are first determined  (see Figure 5). The H-bonding and VDW interactions were then selected 
from this set of nearest neighbors. These are tabulated for clarity and ease of analysis by inspection (see Figure 6).  
Those interactions occurring in all or most of the training structures, and/or those with ideal distances between 
interacting atoms, were selected.  The resulting selection is the 3D binding site consensus motif (3D BS CM) for the 
specific ligand in the protein family under consideration.  The H-bonding and VDW interactions in the 3D LBS CM 
are used to guide the selection of backbone and side chain centroids for inclusion in the 3D SM.  The determination of 
the 3D ligand binding site consensus motif is described in more detail in our previous work (Reyes, V.M. & Sheth, 
V.N., 2011). 
 
Building Reduced Representations of Protein Structures in the Training Set.   The protein structures were transformed 
into DCRR, where each residue is represented by two points: the centroid of the backbone atoms (N, CA, C’, O), and 
the centroid of the side chain atoms (CB, CG, etc.).  DCRR reduces the atomicity of the protein by >76%, making the 
operations more economical without losing too much chemical information.  The conversion of the all-atom PDB 
representation of the protein into DCRR is described in more detail in our previous work (Reyes, V.M. & Sheth, V.N., 
2011). 
 
Determining the 3D SM.    The 3D SM is derived from the 3D LBS CM.   The protein file is transformed into DCRR 
then the nearest neighbors of each ligand atom in the protein are determined.  Then the root and nodes of the 3D SM 
are selected from these nearest neighbor centroids by cross-comparison with the 3D LBS CM (in AAR) determined 
earlier, based on prevalence and agreement of lengths (H-bonds and VDW interactions) to ideal values (Bondi, et al., 
J. Phys. Chem., 68:441, 1964).  
 
Screening for the 3D SM.      The screening procedure for the 3D SM has been described schematically in our previous 
publication (Reyes, V.M. & Sheth, V.N., 2011).  The overall screening algorithm is applied using the 3D SM, which is 
in double-centroid representation (DCRR; see Figure 7, Panel A) and is composed of nine steps (see Figure 7, Panel 
B), all of which are automated except the last, which is done by inspection.  Each of the nine steps is implemented as a 
Fortran 77/90 program; all are incorporated in a script, allowing the user to perform all nine steps at once, but the last. 
 
Validation Tests.   To estimate the sensitivity and specificity of the algorithm for each protein family, positive and 
negative controls were performed.  The positive control structures (n=15) for the GTP-binding small, Ras-type G-
protein family are: 1C1Y, 1GWN, 1NVX, 1PLK, 1QRA, 1ZBD, 3RAP, 521P, 1AS3, 1BOF, 1GIT, 1KAO, 1PLL, 
1TAG and 2RAP.  They are described in Table 2, Panel A. The positive control structures (n=15) for the ATP-binding 
ser/thr protein kinase family are: 1CDK, 1FMO, 1GY3, 1JBP, 1Q24, 1S9I, 1S9J, 1UA2, 2CPK, 1CSN, 1H1W, 1L3R, 
1OGU, 1RDQ and 1CM8.  They are described in Table 2, Panel B.  The negative control structures (n=30) used for all 
protein families are: 135L, 1A1M, 1A6T, 1BHC, 1PSN, 1BRF,   1EWK, 1CBN, 1MV5, 1JFF, 104M, 1ASH, 1B3B, 
1BRF, 1CKO, 1CRP, 1EWK, 1F3O, 1FW5, 1HWY, 1JBP, 1MJJ, 1MV5,   1NQT, 1OGU, 1PE6, 1RDQ, 1SVS, 
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1TWY and 1Z3C. They are described in Table 3.  The screening algorithm was performed on both control sets with no 
distinction between tight and loose binding sites.  Specificity (Sp), sensitivity (Sn), success rate (SR) and the 
Matthews correlation coefficient (MCC) were calculated as follows:  Sp = TN/(TN + FP);  Sn = TP/(TP + FN);   SR = 
(TP + TN)/(TP + TN + FP + FN);   MCC = (TP*TN - FP*FN)/sqrt[(TP + FP)*(TP + FN)*(TN + FP)*(TN + FN)] ;  
where TP = true positives; TN = true negatives; FP = false positives; and FN = false negatives. 
 
3  Results 
 
Determining the 3D Binding Site Consensus Motif for GTP.    
 
Hydrogen-Bonding Interactions.   Based on the protein-ligand H-bonding and VDW interactions common among the 
training structures, the 3D binding site consensus motif (3D BS CM) is determined.  The H-bonding interactions that 
each GTP atom makes with the amino acid residues at the binding site in the receptor protein in each of the training 
structures are first tabulated (data not shown).   The most common H-bonding interactions shared by members of the 
training set involve pyrimidine N1 and ring substituents atoms N2 and O6 of GTP.  In all cases, pyrimidine N1 and 
ring substituent N2 atoms are respectively engaged in ideal H-bonds to atoms OE1 and OE2 of an asp residue, while  
pyrimidine substituent atom O6 is H-bonded to the backbone N of either a lys (one structure) or ala residue (the rest).  
Interestingly, GTP atoms N1, N2 and O6 are precisely the ones involved in base-pairing interactions involving the 
guanylate moiety in ribonucleic acids (RNA).  Pyrimidine N3 and imidazole nitrogens N7 and N9 do not participate in 
any H-bonding interactions in all cases.  Meanwhile, in structures E, F and P, ribose hydroxyl oxygens O2* and O3* 
are engaged in ideal H-bonds with backbone oxygens of a his, val or ile residues, and those of a glu or asp residues, 
respectively, while in structure B, the same ribose oxygens are simultaneously H-bonded to the backbone O of a gly 
residue.  There are no H- bonding interactions involving ribose O2* and O3* in structures M, N and O.  Note that we 
did not consider the binding cavity of the triphosphate moiety of either GTP or ATP because: (1) pyrophosphate 
sometimes binds proteins nonspecifically; (2) phosphate is a common moiety in biological ligands, and, most 
importantly; and (3) the triphosphate tail has a high degree of rotational freedom with respect to the guanosine and 
adenosine moieties (syn and anti conformations), therefore a search motif containing a node or root that corresponds to 
a triphosphate atom is unlikely to have branches and node-edges that have fixed lengths. 
 
Van der Waals Interactions.   As in the previous section, the van der Waals interactions that each GTP atom makes 
with the amino acid residues at the binding site in the receptor protein in each of the training structures are tabulated 
(data not shown).   For simplicity, VDW interactions involving non-C protein atoms (N, O, P and S) are not 
considered if they are already involved in H-bonding interaction/s; this approximation is reasonable as, all other things 
being equal, a H-bonding interaction is about 10 times stronger than a VDW interaction.   The most prevalent protein-
GTP VDW interactions in family 02B involve three amino acid residues: a lys, a phe and a tyr, but is most pronounced 
in structures B, F, N and P.  Specifically, ribose C1*, and pyrimidine C5 and C6 are all within VDW interacting 
distance with CE and CG atoms of a lys, while ribose C2* and pyrimidine C4 both lie close to the CZ atom of a phe; 
finally, ribose C3* and C4* are both close to the CB atom of a tyr. In structure E, ribose C4* and C5* are sufficiently 
close to atom CB of a pro; in structure O, ribose C2* and imidazole C8 lie close to the CB atom of a thr, as well as CA 
of a gly in the other; and finally in structure M, ribose C2* and imidazole C8 lie close to the CD and CG atoms, 
respectively, of two lys residues different from the lys referred to above. 
 
In summary, H-bonding and VDW interactions between GTP and protein prevalent in structures in this family are 
presented in Figure 8, Panel A.   We note that the binding mode of GTP in this family is characterized by polar 
interactions between ligand and protein involving the extremities of the guanosine moiety: pyrimidine N1 and 
substituents N2 and O6 on one end, and ribose O2* and O3* on the other.  It as well features non-polar interactions 
between ligand and protein involving the central portion of the moiety, including the distal edge of the ribose ring 
composed of atoms C3* and C4*.  The four polar atoms in the central part of guanosine – pyrimidine N3, imidazole 
N7 and N9, and ribose O4* - are not engaged in H-bonding with protein.     
 
Determining the 3D Binding Site Motif Consensus for ATP.   
 
Hydrogen-Bonding Interactions.  The procedure was similar to that described for the GTP-binding family the previous 
section.  The most common interactions between ATP and protein are those that involve pyrimidine N1 and 
pyrimidine substituent N6 of the ligand.   In all cases pyrimidine N1 is H-bonded either to a leu or a met backbone N, 
while pyrimidine N6 is H-bonded to either an asp or a glu backbone O.  There is a further pattern: interaction of N1 
                                              
 
5
with a leu and of N6 with an asp are highly correlated; so does the interaction of N1 with a met and N6 with a glu.  
Interestingly, pyrimidine N1 and N6 are precisely the ones involved in base-pairing interactions involving the 
adenylate moiety in RNA.  On the other hand, pyrimidine N3 and imidazole nitrogens N7 and N9, do not participate in 
any H-bond interactions.  The two ribose hydroxyl oxygens O2* and O3* are also involved in several interactions, 
notably (a.) between the backbone O of a gln residue and either ribose O2* (structures A, B and E) or O3* (structures 
G2, I, J1 and J2); (b.) between the OD2 atom of an asp and either ribose O2* (structures D, J1 and J2) or O3* 
(structure E); (c.) between the OE2 atom of a glu and either ribose O2* (structures I and K) or O3* (structure H); and 
(d.) between the NZ atom of a lys and ribose O3* (structure D).    
 
Van der Waals Interactions.  Again, the procedure was similar to that described for the GTP-binding family the 
previous section.  The most common protein-ATP VDW interactions in members of the ser/thr PK training set are 
those between (a.) pyrimidine C6 and either the CB atom of an ala or the CD1 atom of a leu; (b.) imidazole C8 and 
either the CG1 atom of a val or the CD1 atom of a leu, and (c.) ribose C4* and the CA atom of a gly. They occur in all 
13 training structures except the last interaction, which is not present in structure D.   We note that there are 
significantly more protein-ATP carbon-carbon VDW interactions in this training set than protein-GTP VDW 
interactions in the previous 2 training sets.  
 
Figure 8, panel B summarizes the protein-ATP interactions in this training set.  We note that binding of ATP is 
characterized by polar interactions along the extremities of the adenosine moiety, notably involving pyrimidine N1 
and N6 on one end and ribose O2* and O3* on the other.  Meanwhile, the central part of the moiety is characterized 
by non-polar interactions, notably ribose C3* and C4*.  Of interest is the fact that four polar atoms in the central part 
of the adenosine moiety – pyrimidine N3, imidazole N7 and N9, and ribose O4* - are not involved in H-bonding.      
 
Deriving the 3D SM for GTP.     
 
Preliminary Considerations.    The 3D SM (which is in DCRR) may be considered to be the the distillation of the 
physical interactions included in the 3D BS CM (which is in ARR), and the 3D SM is essentially a signature of the 
ligand binding site.  During screening, the ligand is conceptually in AAR while the protein is in DCRR.  Such a ligand 
environment composed of centroids does not represent genuine physical interaction, and for clarity we designate it as 
“association”, and reserve the term “interaction” for actual physical interactions as H-bonding and VDW attractive  
forces.  In constructing the 3D SM, the four most prevalent and/or ideal interactions in the training set are selected, 
and the corresponding centroids are then taken as elements of the 3D SM; these are the protein-ligand associations.  In 
most cases, the best associations are obvious, and it is clear which centroids must be included in the 3D SM. 
Sometimes, however, there is a ‘tie’.  In such cases, the root or one or more nodes in the 3D SM is/are not unique and 
the researcher may incorporate a disjunction (“or”) in the 3D SM.   Since the protein is in DCRR in the 3D SM, we 
shall adopt the notation “X(b)” and “Z(s)” to denote “the backbone centroid of amino acid X” and “the side-chain 
centroid of amino acid Z”, respectively.  We denote a disjunction by a slash, e.g., L(s)/I(s) means ‘leucine side chain 
or isoleucine side chain’ 
 
Association Between Protein Backbone Centroids and Ligand Atoms.  In all the training structures for this family, 
ribose O5* is associated with a G(b), while pyrimidine O6 is associated with an A(b) or a G(b).  Similarly, pyrimidine 
N2 is associated with a K(b), and imidazole C8 is associated with a G(b) - the same G(b) associated with ribose O5*.  
Comparing the above associations against the 3D BS CM, found earlier, we note that ribose O5* is indeed H-bonded 
to the backbone N of a gly residue in all cases except structure M, while pyrimidine O6 is H-bonded to the backbone 
N of an ala residue, except again for structure M where it is H-bonded to the backbone N of a lys, and as well to 
backbones N and O of two different gly residues.  In contrast, pyrimidine N2 is not involved in H-bonding, and there 
is only weak VDW interaction between imidazole C8 and a gly residue.  These findings suggest that G(b) and 
A(b)/G(b), associated respectively with ribose O5* and pyrimidine O6, may be included in the 3D search motif.   
 
Association Between Protein Side-Chain Centroids and Ligand Atoms.   In all the training structures for this family, 
pyrimidine N1 and ribose O4* are associated with a D(s) and a K(s), respectively.  In addition, pyrimidine N3 and C4 
are both associated with the same K(s) above.  Comparing these associations against the 3D BC CM determined 
earlier, we note that in all cases except structure E, pyrimidine N1 indeed forms a H-bond with the OD1 and OD2 
atoms of an asp residue, while ribose O4* is H-bonded the NZ atom of a lys.  Pyrimidine N3, on the other hand, does 
not participate in any interactions except in structure M, where it is H-bonded to the backbone O of a gly and perhaps 
                                              
 
6
as well to the backbone N of a lys.  The above information suggest that D(s) and K(s) may be included in the 3D 
search motif. 
 
Combining the above information with the ones from the previous section, we come up with the 3D SM for this 
family, see Figure 9, Panel A.  The 3D SM is composed of D(s) as root, A(b)/G(b) as node1, K(s) as node2, and G(b) 
as node3, which are associated with pyrimidine N1, pyrimidine O6, ribose O4*, and ribose O5*, respectively, of GTP.   
The lengths of the three branches (Rn1, Rn2 and Rn3) and three node-edges (n1n2, n1n3 and n2n3) complete the 3D 
SM; each is the averages from all the training structures.  In most cases, the standard deviations are less than 1.0 Å, the 
rest being not much greater than 1.0 Å. 
 
Deriving the 3D SM for ATP.    
 
Association Between Protein Backbone Centroids and Ligand Atoms.   In all the training structures for this family, we 
readily observe the following associations: (a.) pyrimidine N6 with a E(b) or an D(b), (b.) pyrimidine N1 with a L(b) 
or a M(b), (c.)  imidazole N7 with an A(b), (d.) ribose O3* with either a E(B) or a Q(b) (except for structure G2), (e.) 
ribose O4* with a G(b), and (f.) pyrimidine C2 and C6 both with a L(b) or a M(b).   Comparing the above associations 
against the 3D BS CM for this family found earlier, indeed we find that pyrimidine N6 is H-bonded to the backbone O 
of either a glu or an asp, validating (a.) above. Similarly, pyrimidine N1 is H-bonded to the backbone N of a leu or a 
met, thus validating (b.) above. In contrast, imidazole N7 is not involved in H-bonding, so (c.) above cannot be 
validated.  The case for ribose O3* is not strong, as it is not H-bonded to a glu or a gln backbone O or N in 5 of the 13 
training structures; we thus rule out (d.) as well.  Cases (e.) and (f.) above are similarly weak.  These findings suggest 
that E(b)/D(b) and L(b)/M(b), associated respectively with pyrimidine N6 and N1, may be included in the 3D search 
motif.   
 
Association Between Protein Side-Chain Centroids and Ligand Atoms.   In all the training structures for this family, 
we readily observe the following associations:  (a.) ribose O2* with an D(s) or a E(s), (b.) pyrimidine N1 and N6 both 
with an A(s), (c.) ribose O4* with either a V(s) or a G(s), (d.) imidazole C8 with a V(s), and (e.) pyrimidine C5 and C6 
both with an A(s).    Again, comparing the above associations against the 3D BS CM for this family found earlier, 
we note that ribose O2* is indeed H-bonded to the OD2 or the OE2 atom of an asp or a glu, respectively, in all cases 
except structures C2 and G2, validating association (a.) above. In contrast, neither pyrimidine N1 nor N6 is H-bonded 
with an ala in any of the 13 training structures, ruling out (b.) above.  Meanwhile, ribose O4* is in H-bonding 
interaction in only 3 of the 13 training structures, and never with a val; thus (c.) above may be eliminated.  Except for 
structure D, imidazole C8 is always in VDW interaction with a val, thus validating (d.) above.  Finally, pyrimidine C5 
and C6 are only weakly involved in VDW interaction with an ala, hence (e.) is eliminated.  The above findings 
indicate that we may include D(s)/E(s) and V(s), which are associated with ribose O2* and imidazole C8 respectively, 
in the 3D search motif for this family. 
 
Combining the above results with those from the previous section yields the four centroids comprising the 3D SM for 
this family, see Figure 9, Panel B.  The 3D SM is composed of  E(b)/D(b) as root, V(s) as node1, D(s)/E(s) as node2 
and L(b)/M(b) as node3, which are associated with pyrimidine N6 and N1, ribose O2* and imidazole C8, respectively, 
of ATP.  The lengths of the three branches (Rn1, Rn2 and Rn3) and three node-edges (n1n2, n1n3 and n2n3) complete 
the 3D SM; as before, each is the averages from all the training structures.  In most cases, the standard deviations are 
less than 1.0 Å, the rest being not much greater than 1.0 Å 
 
The Control Experiments.     
 
Ideally, the positive control structures should be structures which are known to contain the particular 3D SM; 
similarly, negative controls must be structures which are known to not contain the 3D SM.  Since there is no practical 
way of determining the existence of the 3D SM’s in protein 3D structures except by visual examination, we simply 
chose positive controls from the PDB by their similarity to the training structures, and negative controls by their 
dissimilarity with the training structures.  Thus the results of the control tests presented below must be interpreted with 
caution. 
 
Validation Tests for the Small Ras-type G-protein Family.    Fourteen out of the 15 positive controls tested positive 
under the screening algorithm, while all 30 negative controls tested negative.  Thus there are 14 true positives, 1 false 
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negative, 30 true negatives, and 0 false positive.  This suggests that, for this family, our algorithm has a sensitivity of 
93.3%, a specificity of 100.0%, a success rate of  97.8%, and a Matthews correlation coefficient of 95.0%.   
 
Validation Tests for the ser/thr PK Family.   Nine out of the 15 positive controls tested positive under our algorithm, 
while all of the 30 negative controls tested negative.  Thus there are 9 true positives, 6 false negatives, 30 true 
negatives, and 0 false positives.  This suggests that, for this family, our algorithm has a sensitivity of 60.0%, a 
specificity of 100.0%, a success rate of 86.7%, and a Matthews correlation coefficient of 70.7%.   
 
ROC Curves.   Partial ROC curves constructed from the above results using the fact that ROC curves are parabolas 
that pass through the points (0,0) and (1,1) are shown in Figure 10, Panels A (left) and B (right) respectively, for the 
GTP-binding small, Ras-type G-proteins and the ser/thr protein kinase families.   
                            
Expanded Test Sets for the GTP- and ATP- binding families. 
 
To further ascertain the sensitivity of our algorithm to the detection of the GTP- and ATP-binding sites in the two 
protein families, we tested more positive structures for both families using our screening algorithm.   The expanded 
test set (positive structures, n=45) for the Ras-type GP family  are:  1A2B, 1A2K, 1CTQ, 1FZQ, 1GG2, 1GP2, 1GUA, 
1HUQ, 1JAH, 1JAI, 1K5D, 1K5G, 1KAO, 1MH1, 1N6L, 1NVU, 1NVV, 1NVW, 1OIV, 1OIW, 1OIX, 1QRA, 1R2Q, 
1R4A, 1RYF, 1RYH, 1T91, 1WA5, 1WQ1, 1YHN, 1YZT, 1YZU, 1Z08, 1Z0A, 1Z0D, 1Z0J, 1ZBD, 1ZC3, 1ZC4, 
2BKU, 2EW1, 2RAP, 3RAB, 3RAP and 5P21.  They were selected from the PDB by keyword search, “Ras-type G-
protein.”  Using the algorithm to screen them for the 3D SM of the GTP-binding site in the small, Ras-type G-
proteins, all tested positive.  These results indicate that the algorithm has high sensitivity for this family (see Figure 
11, Panel A).  
 
The expanded test set (positive structures, n=31) for the ATP-binding ser/thr PK family are: 1BO1, 1IA9, 1E8X, 
1CJA, 1NW1, 1J7U, 1CDK, 1O6L, 1OMW, 1H1W, 1MUO, 1TKI, 1JKL, 1A06, 1PHK, 1KWP, 1IA8, 1GNG, 1HCK, 
1JNK, 1HOW, 1LP4, 1F3M, 1O6Y, 1CSN, 1B6C, 2SRC, 1LUF, 1IR3, 1M14 and 1GJO.   They are the 31 
representative protein kinase structures used in the paper by Scheeff and Bourne (PLOS CB, 2005).  Using the 
algorithm to screen them for the 3D SM of the ATP-binding site in the ser/thr protein kinase family, all but two tested 
positive.  The two which tested negative were 1CJA and 1NW1, which were classified by Scheeff & Bourne to be 
“atypical protein kinases” due to the atypical architecture of their ATP binding sites.  These results indicate that the 
algorithm has high sensitivity for this family (see Figure 11, Panel B).  
 
Additional Tests to Assess Discriminatory Power of Algorithm.     
 
Screening of Proteins Binding GTP-like Ligands:    To ascertain the ability of  our method to distinguish between GTP 
and GTP-like ligands,  the following proteins that bind GTP-like ligands were randomly selected from the PDB: a 
GDP-binding protein (1kv3), a GMP-binding protein (1znx) and a cyclic GMP-binding protein (1q3e).  Each were 
then screened using the search motif derived from the small Ras-type G-protein family (02B), initially with ε= 1.00 Å.  
All three structures tested negative, being eliminated early on in the screening process. A second screening with a 
more relaxed ε= 1.40 Å similarly produced negative results from all three structures.  These results suggest that the 
ligand binding sites of these proteins are quite different from that of family 02B, and that our algorithm can effectively 
differentiate between them.   
 
Screening of Proteins Binding ATP-like Ligands:   To ascertain the ability of  our method to distinguish between ATP 
and ATP-like ligands,  the following proteins that bind ATP-like ligands were randomly selected from the PDB: a 
SAH-binding protein (10mh), a NAD-binding protein (1axe) an ADP-(and FAD-) binding protein (1cnf), an FAD-
binding protein (1jrx), an AMP-(and FAD-) binding protein (1t9g), and a cAMP-binding protein (1ykd).  Each were 
then screened using the search motif derived from the ser/thr PK protein family (01a), initially with ε= 1.00 Å.  Five of 
the six structures yielded negative results, while structure 1jrx gave a positive result.  Upon closer inspection, 
however, the putative ATP-binding site signature detected by the algorithm in structure 1jrx (namely, Asp-513, Val-
539, Asp-358 and Met-511)  turned out to be a spurious motif that is about 15 Å away from the genuine FAD binding 
site.  This motif, although apparently resembling the ser/thr PK search motif, most probably does not have biological 
significance and occurred by chance.    A second screening with a more relaxed ε= 1.40 Å again produced negative 
results from the same 5 of the 6 structures as before, but picked up a new putative ATP binding site signature in 
structure 1jrx.  Upon closer inspection, this second ATP-binding site (namely, Glu-156, Val-294, Asp-125 and Leu-
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154) was indeed located approximately where the adenosine moiety of FAD is bound in the protein (data not shown).  
However, the interaction of the residues in the search motif with the FAD adenosine moiety was only partial: that is, 
although carboxyl atoms OE1 and OE2 of Glu-156 (the root) are ideally H-bonded to the ribose hydroxyls AO3* and 
AO2* of the FAD adenosine moiety (at 2.67 Å and 2.51 Å, respectively), atom CG1 of Val-294 (node 1) is in VDW 
interaction not with FAD adenosine AC8 but with AN1, and the interaction is weak (at 6.97 Å); atom C of Leu-154 
(node 3) is in VDW interaction not with FAD adenosine AN1 but with AC2, and the interaction is even weaker (at 
7.74 Å); and Asp-125 (node 2) is not in H-bonding at all with any FAD adenosine atom.    Taken together, these 
results demonstrate that our algorithm can effectively differentiate the ATP-binding site of the ser/thr PK family from 
the ATP-like ligand binding sites of the above proteins.     
 
Comparison of Method with Global Structure-Based Methods.   To demonstrate that the present method, which is 
local structure-based, works where global structure-based methods do not, consider the set of ATP-binding proteins 
with differing global folds but with similar ATP-binding site architectures, compiled by Kobayashi & Go (1997a; 
1997b). Using the 4 ATP-containing structures in the set - 1cdk, 2dln, 1csn and 1gsa -  for training, the ATP-binding 
site consensus motif determined from them yields the following 3D search motif:  {root = L(b)/V(b);  node1 = 
D(b)/K(b)/E(b)/N(b);  node2 = L(s)/I(s)/V(s);  node3 = D(b)/D(s)/E(b)/E(s); length Rn1 = 6.152; length Rn2 = 7.731; 
length Rn3 = 10.334; length n1n2 = 7.765; length n1n3 = 13.894; and length n2n3 = 10.279; with ε = 1.00 Å}.  This 
search motif was used to screen the other 8 structures in the group -  2glt, 1scub, 1bnc, 1irk, 1dik, 1gtr, 1ses and 1lgr. 
All 8 tested positive (data not shown).  This confirms that our algorithm can pick up all of these structures despite the 
fact that they have differing overall global folds.   When the four training structures were inputted into the fold-based 
method, DALI, only training structures 2dln and 1gsa were able to pick up structures in the test set: 1bnc and 1dik.  
Even so, the ranks were low (2dln picked up 1bnc with rank 5, and 1dik with rank 12; 1gsa picked up 1bnc with rank 
7, and 1dik with rank 14) and the RMSD’s were high (2dln picked up 1bnc with RMSD of 6.0Å, and 1dik with RMSD 
of 3.1Å; 1gsa picked up 1bnc with RMSD of 5.4Å, and 1dik with RMSD of 3.7Å).  The other two training structures 
(1cdk and 1csn) did not pick up any structure from the test set.  Thus six of the eight test structures were invisible to 
DALI.  The above results demonstrate that the present algorithm, being local-structure-based, is able to assign 
function to proteins where global fold-based methods such as DALI fail.  
 
Benchmark Experiment: Use of Predicted Structures.  We applied our method to the newly-sequenced proteome of the 
slime mold, Dictyostelium discoideum (Eichinger et al., 2005).  A subset of the slime mold proteome was used to build 
3D structures models of proteins from primary sequence using the threading program, 123D (Alexandrov et al., 1995), 
and the side chain modeling and partial refinement program, Modeller 6.2 (Sali et al., 1993).  We selected proteins 
which did not have functional annotation at the time. The resulting protein models, 400 in all, were screened using the 
3D SM for the two protein families.   47 structures tested positive for the Ras-type G-protein family, of which 10 have 
‘tight’ binding sites (ε ≤ 1.0 Å), and 37 have ‘loose’ binding sites (1.0 Å ≤ ε ≤ 2.0 Å).  Meanwhile, 52 structures tested 
positive for the ser/thr protein kinase family, of which 46 have ‘tight’ binding sites, and 6 have ‘loose’ binding sites 
(data not shown). These sets of structures have common elements. Preliminary independent results support the above 
findings.  Most notably, a Dictyostelium protein containing the FNIP domain (marked by phe-asn-ile-phe repeats), 
which is of unknown function and occurring exclusively in amoeboid proteomes, has been found to possess the GTP 
binding site using our algorithm.  Thus, our method seems to hold promise for function prediction using predicted 
structures, instead of experimentally solved structures.   
 
4  Discussion 
 
Salient Features of the Method.   In the following sections, we discuss the salient features of our method and try to 
relate them to existing methods that have the same objective of predicting functional sites in protein 3D structures.   
 
Ability to Detect Consensus Binding Sites in Proteins of Different Folds.  From the foregoing sections, it is obvious 
that the present method achieves the detection of three-dimensional motifs in the binding sites of 3D protein structures 
by nearest- neighbor analysis of the bound ligand, and not by C-α alignment of protein structures.  Such is an 
important consideration because it is known that proteins of different folds – which are not C-α alignable – can and do 
bind the same ligand using the same 3D binding site consensus.  This is one strength of the present method. 
 
Inherent Objectivity.   The 3D SM in our method is based purely on protein-ligand H-bond and VDW interactions - 
information that is completely derivable from the PDB file.  Similar existing methods involve construction of 
‘templates’ based on catalytic site residues, determined with unavoidable subjective input from the experimenter and 
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derived by human perusal of the literature.  The fact that our approach is based on binding residues instead of catalytic 
residues means it is more objective than other similar methods. 
 
Ligand Specificity.  Other existing methods of functional site prediction involves merely specifying local sections of 
the protein 3D structural surface that are biologically important, without providing information exactly what the local 
site does – e.g., is it a catalytic site? is it a ligand binding site, and if so, what specific ligand does it bind? is it 
involved in protein-protein interaction, and if so, what is the partner protein?.  In contrast, our method is ligand- 
specific: the researcher decides on the specific ligand for study, then collects a set of training structures from the PDB 
containing that ligand.  Such ligand-specificity makes functional assignment more straightforward and objective.  
 
Extensibility and Scalability.  Our method is amenable to automation and thus well-suited for large-scale function 
assignment to entire proteomes. Other methods involve molecular dynamics simulations, and hence not easily 
automatable.  Here, our method is applied to ATP and GTP binding site prediction, but it is also applicable to other 
ligands.  Recently we have used it to predict sialic acid, retinoic acid, and heme-bound and unbound nitric oxide 
binding sites in experimentally solved protein structures in the PDB that currently do not have functional annotation 
(Reyes, V.M., unpublished [a.]).  We have also  extended the method to the prediction of specific protein-protein 
interaction partners (Reyes, V.M., unpublished [b.]).  These applications demonstrate  the extensibility and the 
versatility of the method.  Additionally, the present method can be applied to non-protein structures, such as 
carbohydrate and lipid structures, which do not possess “standard” monomers (e.g., amino acids). 
 
Analytical Nature.   Other methods of protein functional site prediction make use of traditional machine learning 
techniques such as SVM, etc.  Being statistical in nature, these methods do not allow the researcher full control over 
the classification process and involves some inexactitude in the results.  In contrast, our algorithm is analytical, and as 
such it is one of only a handful of deterministic methods of functional site prediction currently available.    
 
Local Structure Dependence.   Our algorithm is designed to detect protein ‘local structures’ - the constellation of 
amino acid residues that come together in 3D space when the protein folds to assume its 3D structure (see Figure 1).  
The 3D SM defined in this work is precisely such a constellation of residues in space; our algorithm detects this 
spatial arrangement of residues in the input structure.  A key concept here is that proper folding of the protein into its 
correct 3D structure is a prerequisite to the correct assembly of local structure.  
 
Use of Novel ‘Tree’ Data Structure.  To implement our algorithm, the 3D SM must be in ‘tree’ data structure, 
composed of a unique root, and typically 3 nodes, which together form an irregular tetrahedron.  The qualitative and 
quantitative input parameters of the algorithm are all embodied in the 3D SM -  the amino acid identities of the root 
and nodes, their interaction type (side chain or backbone), and the lengths of the 6 edges of the tetrahedron.  The 
lengths of the 6 edges are determined by direct calculation from the atomic coordinates.  Thus the optimal input 
parameter values are essentially dictated by the ligand’s molecular dimensions.  Although in theory the search motif 
can have 2 or more than 3 nodes, pilot tests demonstrate that a search motif composed of exactly 4 centroids (1 root 
and 3 nodes) has sufficient sensitivity and specificity to detect genuine ligand binding sites. Including even one more 
node results in a steep increase in computation time but little improvement in accuracy.  Thus in this work we use 
search motifs composed of exactly 1 root and 3 nodes. 
 
Consideration of H-Bond and VDW Interactions Between Protein and Ligand.   Our method takes into account both 
H-bonds and VDW interactions in building the 3D SM.  Other methods consider only polar interactions (i.e., H-bonds) 
between ligand and protein. However, ligand stabilization at the active site does not depend solely on H-bonding 
interactions; VDW attractive forces also play a significant role.  Although a typical H-bond (2 - 10 kcal/mol) is about 
10 times stronger than a typical VDW attractive force (0.1 to 1.1 kcal/mol), in our protein-ligand systems (ligand = 
ATP or GTP), there are approximately 8-9 VDW attractive forces per H-bond.  It may thus be concluded that the 
contributions of H-bonding and VDW attractive force to ligand stabilization at the binding site are roughly of the same 
order of magnitude. This is most likely to be true in general.  
 
Use of Double Centroid Residue Reduced Representation.  Other methods use CA atoms to represent amino acid 
residues; this is not ideal, as it results in significant loss of information (see next section).  Our method makes use of 
the ‘double centroid residue representation’ during screening for the ligand binding site. In DCRR, each protein 
residue is represented by two points: the centroid of its backbone atoms (N, CA, C’ O), and the centroid of its side 
chain atoms (CB, CG, etc.,).  Although the protein’s atomicity is reduced by >76% compared to >88% using CA 
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atoms, it is more than compensated for by the greater resolution and accuracy achieved (see below).  A DCRR-like 
representation has been used before (Kleywegt, 1999), but unbeknownst to the author during the early stages of this 
study.  Use of reduced protein representations such as DCRR also adds a fuzzy element into the screening process, 
thus counteracting the inherent uncertainty in screening predicted structures.  Even in instances where the input 
structures are experimental or predicted with high accuracy, use of DCRR minimizes uncertainties resulting from 
protein dynamics and flexibility.   
 
Consideration of Both Protein Side Chain and Backbone Interactions.  Just as consideration of protein global fold 
alone is insufficient in predicting protein function, consideration of primary sequence alone is also ineffective.  First, 
to consider sequence alone means to neglect protein folding altogether.  During protein folding, often residues that are 
nonconsecutive and/or separated by any number of residues in the primary sequence come together in 3D space to 
form the local structure.  Second, the backbone N-H and/or C=O of one or more binding residues are commonly 
involved in H-bonding with certain ligand atoms. This enables their corresponding side chains to almost freely assume 
any identity, thus allowing a high degree of sequence variation at these sites.  Our method gives equal consideration to 
both backbone-ligand and side chain-ligand interactions.  About 40% of all protein-ligand H-bonds in the training 
structures involve the protein N or O backbone atoms, while the rest involve side-chain functional groups; it is thus 
clear that protein backbone-ligand and protein side chain-ligand interactions  both contribute significantly to the 
stabilization of the bound ligand.   
 
Use of Fuzzy Additive Term. Our method incorporates am error margin, ±ε, as an element of “fuzziness” to the 
screening process that is meant to minimize and/or counteract the inherent uncertainty in predicted structures and/or 
counteract the effects of protein flexibility.  
 
Semi-Docking Nature of Method.   Our method may be considered a semi-docking procedure.  This is because not 
only is the precise geometry of the 3D SM known, but also the identity of its root and nodes.  Thus the algorithm can 
search for the specific amino acids and their mode of interaction with the ligand (via backbone or side chain).  
Similarly, the specific ligand atoms interacting with the root and nodes are also precisely known.  Thus the precise 
orientation of the ligand relative to its binding site in the protein is precisely determined.  This is an advantage over 
existing methods which simply identify the location of functional sites. 
 
Limitations of the Method.    
 
First, we have currently no provision to automatically (computationally) ascertain the relative location of the detected 
3D SM in the protein, i.e., whether it is located  on the surface, lodged in a deep crevice, or close to the protein 
centroid.  To this end, we have recently developed two complementary algorithms to quantify the degree of burial of 
ligand binding sites in proteins called the ‘cutting plane’ and ‘tangent sphere’ methods (V. M. Reyes, unpublished 
[c.]).   Second, the error margin, ε, incorporated into the branch and node-edge lengths is usually in the order of 1.0 – 
1.5 Å.  Thus in cases where the protein assumes drastic conformational changes upon ligand binding, our method 
might fail.  Third, in the determination of H-bonds between protein and ligand, we do not ascertain the linearity of the 
bonds of the interacting atoms - we merely measure non-hydrogen interatomic distances.  However this issue is 
unlikely to have a significant effect on our results, as we sequester only those with perfect or near-perfect H-bond 
distances (2.7Å-2.9 Å).  Cases in which the H-bonding atoms have perfect or near-prefect H-bonding distances and at 
the same time non-linear, are quite rare.   
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Figure Legends: 
 
Figure 1.   Preservation of Protein Local Structure Regardless of Global Structure.   The basic underlying idea 
behind much of the rationale for the work presented here is shown.  The ligand binding site, a local structure, is 
formed by the coming together in 3D space of residues usually far apart and in no particular sequence in the protein 
primary sequence. The ligand binding residues may be conserved to varying degrees, as the interaction with ligand 
may be via side-chain or via backbone.  Thus, ligand binding sites are created from primary structure through protein 
folding.  This requirement for precise protein folding in the creation of such biologically important local structures is a 
major reason why they are more effective in assigning function to proteins than primary sequence (no protein folding) 
and overall global fold (imprecise protein folding and neglect of side chains).  
 
Figure 2.  The Overall Methodology.  The overall methodology may be regarded as being composed of two parts: 
Part I: the 3D motif consensus and search motif determination (left half), and Part II: the actual application of the 
screening procedure itself to an application/test set (right half), taking information ‘learned’ from (Part I).  In this 
diagram, the test/application set in (Part II) is depicted as having been predicted from threading (123D) and modeling 
(Modeller6v2) as in the present work, but they may also be experimentally solved structures, e.g., from X-ray 
crystallography and protein NMR.   
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Figure 3.  All-Atom Representation vs. Double-Centroid Reduced Representation.  The double-centroid reduced 
representations (DCRR) is derived from the all-atom representation (AAR).  In DCRR, each residue is ‘split’ into 
backbone atoms (N, CA, C’, O) and side chain atoms (CB, etc.), the centroid of each group computed, and the residue 
represented by the two centroids.  An artificial ligand is shown interacting with residues at its binding site; the 
interactions in the all-atom representation are H-bonds and VDW attractive forces; in DCRR, they are non-physical 
interactions, and we call them ‘associations.’  
 
Figure 4.   General Structure of the 3D Search Motif.  The general structure of the 3D search motif is an irregular 
tetrahedron, with one corner designated as the ‘root’, R, and three others, the three ‘nodes’, n1, n2 and n3.  As such it 
is also called a ‘tree’ data structure. Higher-order irregular polyhedra such as a pentahedron, etc., are possible, but not 
as computationally efficient for use as a tetrahedron (see text).   Edges emanating from the root are called ‘branches’, 
while those that join two nodes are designated ‘node-edges.’  The root and nodes represent amino acid residue 
centroids (backbone or side chain) in association with ligand atoms.     
 
Figure 5.  Nearest Neighbor Analysis of a Ligand Bound in Its Binding Site in a Protein.  The first step is to find 
the spheres with centers at each atom in the ligand and with radii typically 4.0 Å; this is done for all structures in the 
training set.  Amino acid atoms in the protein binding site lying within these spheres are taken and further processed.  
Those which can potentially hydrogen bond or form van der Waals interaction with any ligand atoms (with correct 
distances and atom identities, see Reyes, V.M. & Sheth, V.N., 2011), are taken and further analyzed to determine 
which of them are the most common among all the structures in the training set (see next Figure).  
 
Figure 6.  Determination of the 3D Binding Site Motif Consensus from Results of Nearest Neighbor Analysis. 
A table is constructed with the training structures as the columns and each ligand atom as the rows; in the figure is a 
theoretical ligand with 12 atoms, and there are 10 protein structures in the training set.   Each cell in the table contains 
all possible H-bond and VDW pairs between the ligand atoms and amino acid atoms in the binding site of the 
particular training structure.  Those which recur with greatest frequency among the training structures are encircled: 
red for ligand atom 2, green ligand atom 5, blue for ligand atom 8 and purple for ligand atom 12.  These four ligand 
atoms are then taken to be the 3D binding site motif consensus for this specific ligand; since there are four of them in 
3D space, they form a tetrahedron.  
 
Figure 7 (A, B).  The Search Algorithm Illustrated for a Theoretical  Ligand and its Protein Receptor. Panel A 
shows a theoretical 3D SM with nodes of the tree-structured 3D motif  labeled (one root and three branch nodes, 
branches and node-edges), as well and theoretical distances between each nodes and the fuzzy additive term, ϵ.   Panel 
B shows the 3D SM search algorithm in finer detail.   The boxed items in green are Fortran programs (namely, 2, 3a, 
3b, 5, 6, 8, 10, 12 and 13) that take input(s) and produce output(s), as indicated by the arrows, and appropriately 
labeled.  Note that the very first input is the protein structure in all-atom representation (AAR), and the very final 
output is the 3D SM. The eight programs (excluding 13, which is currently done by inspection) have been 
incorporated together into one script and may be executed in one keystroke. 
 
Figure 8 (A, B). The 3D Binding Site Motif Consensus for the GTP- and ATP-binding Families. The 3D binding 
site consensus motif for GTP in the small, Ras- type G-protein family (Panel A), and for ATP in the ser/thr protein 
kinase family (Panel B) are shown.  The triphosphate portion of either ligand is not shown in full, as it is disregarded 
in determining the consensus (as well as in building the 3D search motif).  The protein residues engaged in these 
interactions are drawn in short-hand notation, i.e., two perpendicular arrows intersecting at the midpoint of one (the 
backbone part) and at the endpoint of the other (the side chain part), which we call the ‘backbone arrow’ and ‘side 
chain arrow’, respectively.  The arrowhead of the backbone arrow represents the backbone carbonyl oxygen, its 
midpoint the C-α atom and its endpoint the backbone amide nitrogen.  The arrowhead of the side chain arrow 
represents either the H-bonding or the terminal atom in the side chain, as the case may be.  The one-letter designations 
of the amino acid residues are indicated; the forward slashes indicate disjunction (“or”). The red dashed lines are H-
bonds, and the blue ones VDW interactions, between protein and ligand atoms.    
 
Figure 9 (A, B).  The 3D Search Motifs for the GTP- and ATP-binding Families.   The 3D search motifs derived 
from their respective consensus motifs are shown for the GTP-binding families, small Ras-type G-proteins (Panel A) 
and mRNA capping enzymes (Panel B), and the ATP-binding family ser/thr protein kinases (Panel C).  The ligands 
are shown with their standard atom designations, except for the triphosphate tail, only whose location is shown.  The 
root and three nodes of the search motifs are indicated as R, n1, n2 and n3, respectively.  Shown also are the one-letter 
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designations of the amino acid residues in association with the ligand atoms, the qualitative input parameters of the 
algorithm. Each is shown in DCRR as an arrowhead connected by a dashed line to a circle; the former represents the 
residue’s side chain centroid, while the latter, the residue’s backbone centroid.   The lengths of the six sides of the 
search motif (tetrahedron), which are the quantitative input parameters of the screening algorithm, are shown in the 
small table at the bottom right of the figure.  
   
Figure 10.   Partial ROC Curves.   Partial ROC curves deduced from a single operating point on the curve are shown.  
Such ROC curves are shown for the GTP-binding small, Ras-type G-protein family (Panel A, left), and the ATP-
binding ser/thr protein kinase family (Panel B, right).   The operating point on each curve is within the high-specificity 
band;  that in panel A (for GTP binding) is also within the high sensitivity band, while that in panel B (for ATP 
binding) is within the high-middle sensitivity band. 
 
Figure  11,   Validation Screening Results.  Panel A:  GTP Binding Site Screening Results from the small Ras-Type 
G-Protein Family. The Venn Diagram summarizes the results of the screening of the screening of the small ras-type 
G-protein expanded validation set composed of 45 protein structures.  Note that the screening is 100% successful: the 
algorithm detected GTP- binding site in all the test proteins.  Panel B:  ATP Binding Site Screening Results from the 
Protein Kinase Family. The Venn Diagram summarizes the results of the screening of the ser/thr protein kinase 
expanded validation set composed of 31 protein structures.  Note that the algorithm found the ATP binding site in all 
but two (1CJA and 1NW1) of the 31 structures.  Note also that even for the structures that contained no ATP nor ATP 
analog, the algorithm detected ATP binding sites in all but one (1NW1; right circle).      
 
 
 
TABLE CAPTIONS: 
 
Table 1.  Panel A.   Training set for GTP-binding proteins.   
Table 1,  Panel B.   Training set for ATP-binding proteins.   
 
Table 2.  Panel A.   Positive Controls for GTP-binding proteins.  See also page 6 of text for expanded control set.  
Table 2,  Panel B.   Positive Controls for ATP-binding proteins.  See also page 7 of text for expanded control set. 
 
Table 3.    Negative Controls for GTP- and ATP-binding proteins.   
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FIGURE 8 B. 
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                                       FIGURE 10,  Panels A (right) and B (left). 
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FIGURE  11 A. 
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FIGURE 11 B. 
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TABLES: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1 A:    Training Set for GTP-Binding Proteins (families 02B and 02G): 
_________________________________________________________________________________ 
 
PDB ID     E.C. No.             Protein Description                                                                   Family 
_________________________________________________________________________________ 
 
1C4K        4.1.1.17       Ornithine Decarboxylase Mutant (Gly121Tyr)                                  N/A 
 
1E96         N/A              Structure of RAC/P67Phos Complex                                                02B 
 
1FRW       N/A              Structure of E. coli MOBA with Bound  GTP and Mn                      N/A 
 
1JFF         N/A              Refined Structure of Alpha-Beta Tubulin from                                02D 
                                     Zinc-Induced Sheets Stabilized with Taxol 
 
1N6L         N/A             Crystal Structure of Human Rab5A A30P Mutant                            02B 
                                     Complexed with GTP 
 
1NVU        N/A             Structural Evidence for Feedback Activation by Ras-GTP             02B 
                                     of the Ras-Specific Nucleotide Exchange Factor SOS 
 
1P16        2.7.7.50         Structure of an mRNA Capping Enzyme Bound to                        02G  
                                      the Phosphorylated Carboxyl Terminal Domain of 
                                      RNA Polymerase II 
 
1TUB       N/A                Tubulin Alpha-Beta Dimer, Electron Diffraction                             02D 
 
1A9C       3.5.4.16         GTP-Cyclohydrolase I (C110S Mutant) in Complex w/ GTP           N/A 
 
1CKM      2.7.7.50         Structure of 2 Different Conformations of mRNA                           02G 
                                      Capping Enzyme in Complex with GTP 
 
1HWX      1.4.1.3           Crystal Structure of Bovine Liver Glutamate                                  02K 
                                       Dehydrogenase Complexed w/ GTP, NADH & L-Glu 
 
1HWZ      1.4.1.3           Bovine Glutamate Dehydrogenase Complexed with                      02K 
                                      NADPH, Glutamate and GTP 
 
1LOO       6.3.4.4          Crystal Structure of the Mouse Muscle Adenylo-                           02B 
                                      succinate Synthetase Ligated with GTP 
 
1M7B        N/A              Crystal Structure of RND3/RHOE: Functional Implications           02B 
 
1O3Y        N/A              Crystal Structure of Mouse ARF1(Delta17-Q71L), GTP Form         02B 
 
2RAP        N/A              The Small G-Protein RAP2A in Complex with GTP                         02B 
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Table 1 A,B.   The Training Structures for the GTP- and ATP-binding Families  
 
 
 
 
 
 
 
 
 
 
 
Table 1 B:    Training Set for ATP-Binding Proteins (family 01a): 
_______________________________________________________________ 
 
PDB ID     E.C. No.             Protein Description                                                       Kinase Type 
________________________________________________________________________________ 
 
1B38     2.7.1.37            Human Cyclin-Dependent Kinase 2                                       CDK2 
 
1B39     2.7.1.37            Human Cyclin-Dependent Kinase 2                                       CDK2 
                                       Phosphorylated on Thr 160  
 
1FIN       2.7.1.-             Cyclin A-Cyclin-Dependent Kinase 2 Complex                     CDK2  
 
1GOL     2.7.1.-             Rat MAP Kinase ERK2 with an Arg  Mutation                        MAPK 
                                      at Position 52 
 
1HCK     2.7.1.37          Human Cyclin-Dependent Kinase 2                                        CDK2 
 
1JST      2.7.1.-              Phosphorylated Cyclin-Dependent Kinase 2                        CDK2 
                                       Bound to Cyclin A 
 
1PHK     2.7.1.38          Two Structures of the Catalytic Domain of                            Phos. Kin. 
                                      Phoshorylase Kinase: An Active Protein Kinase 
                                      Complexed with Nucleotide, Substrate-Analogue  
                                      and Product 
 
1QL6     2.7.1.38           The Catalytic Mechanism of Phosphorylase Kinase            Phos. Kin.    
                                      Probed by Mutational Studies 
 
1QMZ    2.7.1.-              Phosphorylated CDK2-Cyclin A-Substrate Peptide              CDK2 
                                      Complex 
 
2PHK    2.7.1.38           The Crystal Structure of a Phosphorylase Kinase                Phos. Kin. 
                                      Peptide-Substrate Complex: Kinase Substrate 
                                      Recognition  
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Table 2 A.   
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Table 2 B.    
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Table 3.   The Negative Control Structures for the GTP- and ATP-binding Families 
 
